Navigation Links
InterMune Reports Third Quarter 2012 Financial Results And Business Highlights
Date:11/7/2012

securing coverage from private insurance plans and reimbursement from public (provincial) drug reimbursement plans in Canada; and (vii) InterMune's ability to obtain or maintain patent or other proprietary intellectual property protections.  The risks and other factors discussed above should be considered only in connection with the fully discussed risks and other factors discussed in detail in the Form 10-K, Form 10-Q and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web site at www.intermune.com.Esbriet® is a registered trademark of InterMune, Inc. 

Financial tables follow:InterMune, Inc.PRELIMINARY CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(unaudited, in thousands, except per share amounts)Three Months EndedNine Months EndedSeptember 30,September 30,2012201120122011Revenue, net  Esbriet

$

7,534$

118

$

17,952$

118  Collaboration revenue-0-2,629Total revenue, net7,53411817,9522,747Costs and expenses:  Cost of goods sold2,0173856,200385  Research and development26,17517,04574,55353,967  Selling, general and administrative23,75423,65275,68062,661Total costs and expenses51,94641,082156,433117,013Loss from operations(44,412)(40,964)(138,481)(114,266)Interest income148131452390Interest expense(2,031)(1,281)(6,473)(4,154)Other income (expense)975(227)(149)(322)Loss from operations before income taxes(45,320)(42,341)(144,651)(118,352)Income tax expense192-326-Loss from continuing operations (45,512)(42,341)(144,977)(118,352)Discontinued operations:Income from discontinued operations1324,0972,1258,111Gain on sale of discontinued operations--51,335-Income from discontinued operations1324,09753,4608,111Net loss

$

(45,380)$

(38,244)

$

(91,517)$

(110,241)Basic and diluted net income (loss) per common share:Continu
'/>"/>

SOURCE InterMune, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. InterMune To Release Third Quarter Financial Results On November 7
2. InterMune To Present At JMP Securities Healthcare Conference
3. InterMune to Release Fourth Quarter and Full Year Financial Results on February 9
4. InterMune to Present at J. P. Morgan Healthcare Conference
5. InterMune to Report Unaudited Fourth Quarter Esbriet® Revenue and Business Update on January 5
6. PharmAthene Reports Third Quarter 2012 Financial Results
7. VisionGate Reports Advances In Its Cell-CT(TM) Automated 3D Cell Analysis Platform At ASC 2012 Scientific Meeting
8. Patient Safety Technologies Reports Third Quarter 2012 Results
9. PDI Reports 2012 Third Quarter Financial Results
10. Pharmacyclics Reports Fiscal 2013 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 54th American Society of Hematology Annual Meeting
11. Neurocrine Biosciences Reports Third Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 TaiGen Biotechnology Company, Limited ("TaiGen") today announced ... a leading Russian pharmaceutical company, to develop and commercialize ... Federation , Turkey and ... a novel antibiotic for the treatment of bacterial infections ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider of ... regulatory, business, and media events in the United States ... former associate Virginia Cox , JD, is returning to the ... Virginia Cox re-joins 3D after more than two years of ...
(Date:1/14/2014)... and BETHESDA, Md. , ... joining together with two institutes from the National Institutes ... tools for bringing safer, more effective treatments to patients ... National Center for Advancing Translational Sciences (NCATS) and the ...
(Date:1/14/2014)... Global Record Systems, LLC, (GRS), a ... for patients, physicians, the biopharmaceutical industry, regulators, payers, ... signing of a three-year Research Collaboration Agreement (RCA) ... This initiative is designed to generate disruptive ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Former FDA Associate Commissioner Returns To 3D Communications 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... trying to justify RFID investment wholly on the basis ... in their supply chain are merely deluding themselves. In ... these areas, it means that gross inefficiencies exist in ... improvements even without applying RFID. , ,The benefits of ...
... Software is partnering with Brooktrout Technology to ... , ,The addition of Brooktrout TR1034 intelligent fax boards to ... integrate real-time fax over IP with their VoIP networks, allowing ... and migrate to an IP-based system in the future as ...
... Care , a not-for-profit network of healthcare services in ... NetScaler, Inc. , for a new high-performance network. ... usage and response time across its network of more ... care clinics, home health care services. , ,System architect ...
Cached Biology Technology:The key to finding RFID's ROI 2The key to finding RFID's ROI 3The key to finding RFID's ROI 4
(Date:4/17/2014)... Current Biology on April 17 have discovered ... Brazilian insects, which represent four distinct but related species ... example of an animal with sex-reversed genitalia. , ... animals, Neotrogla is the only example in ... Yoshizawa from Hokkaido University in Japan. , During copulation, ...
(Date:4/17/2014)... the process whereby the genetic information of DNA ... proteins, which have numerous different functions in living ... intermediary during gene expression, by relating the genetic ... in manufacturing proteins. , By examining the ... in an organism at a given time, researchers ...
(Date:4/17/2014)... full of wild animals and plant life, but there,s ... churning away in the soil, decomposing organic matter and ... role these fungi play in ecological systems, their identities ... scientists has generated a genetic map of more than ... was published this week in the Proceedings of ...
Breaking Biology News(10 mins):In sex-reversed cave insects, females have the penises 2Rapid and accurate mRNA detection in plant tissues 2Stanford biologists help solve fungal mysteries 2Stanford biologists help solve fungal mysteries 3
... gases such as CO 2 , which are now known to ... for a number of years. In contrast to the atmosphere, the ... higher. In the global carbon cycle the sea ab-sorbs a proportion ... into the at-mosphere again. About half of the anthropogenic emission ...
... tomography (PET) imaging, seeing is believing: Evaluating a ... typically involves visual interpretation of scans of cancer ... indexone that reflects the reduction of metabolic activity ... responses to first-line chemotherapy, according to a study ...
... Todays Answers, Tomorrows Questions taking place in London ... brings together policymakers, researchers and natural scientists with what ... research in the field of genomics - the Economic ... DNA, genes and chromosomes are often described as ...
Cached Biology News:New ETH Zurich article published in scientific journal 'Nature' 2Quantitative PET imaging finds early determination of effectiveness of cancer treatment 2From GM farm animals to embryonic stem cell research 2From GM farm animals to embryonic stem cell research 3
... The Finnpipette BioControl is a major ... A complete liquid handling system - ... interchangeable tip cone modules. All five ... cone modules fit one handle. The ...
Sulfadimethoxine (CH-2027)...
alpha-N-Catenin Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Bovine Endometrium Epithelial Cells (BEnEpC) (>500,000 cells)...
Biology Products: